EDGAR Filing Documents for 0001213900-15-005829

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-15-005829

Filing Date

2015-08-07

Accepted

2015-08-07 16:43:14

Documents

Period of Report

2015-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	f10q0615_actiniumpharma.htm	10-Q	559080
2	AMENDMENT TO THE AMENDED AND RESTATED BYLAWS	f10q0615ex3i_actinium.htm	EX-3.1	37358
3	FIRST AMENDMENT TO 2013 AMENDED AND RESTATED STOCK PLAN	f10q0615ex10i_actinium.htm	EX-10.1	15872
4	FIRST AMENDMENT TO 2013 AMENDED AND RESTATED EQUITY INCENTIVE PLAN	f10q0615ex10ii_actinium.htm	EX-10.2	8571
5	FORM OF INDEMNIFICATION AGREEMENT	f10q0615ex10iii_actinium.htm	EX-10.3	71286
6	AMENDED AND RESTATED CONSULTING AGREEMENT, DATED JULY 14, 2105, BY AND BETWEEN A	f10q0615ex10iv_actinium.htm	EX-10.4	79951
7	AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED JULY 14, 2105, BY AND BETWEEN A	f10q0615ex10v_actinium.htm	EX-10.5	81348
8	AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AUGUST 6, 2015, BY AND BETWEEN ACTINIUM	f10q0615ex10vi_actinium.htm	EX-10.6	6649
9	CERTIFICATION	f10q0615ex31i_actinium.htm	EX-31.1	14426
10	CERTIFICATION	f10q0615ex32i_actinium.htm	EX-32.1	7588
17	GRAPHIC	image_002.jpg	GRAPHIC	6575
	Complete submission text file	0001213900-15-005829.txt		3902243

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE FILE	atnm-20150630.xml	EX-101.INS	584458
12	XBRL SCHEMA FILE	atnm-20150630.xsd	EX-101.SCH	46866
13	XBRL CALCULATION FILE	atnm-20150630_cal.xml	EX-101.CAL	26804
14	XBRL DEFINITION FILE	atnm-20150630_def.xml	EX-101.DEF	153114
15	XBRL LABEL FILE	atnm-20150630_lab.xml	EX-101.LAB	396873
16	XBRL PRESENTATION FILE	atnm-20150630_pre.xml	EX-101.PRE	256748

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036

Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

Filing Detail